US › Healthcare

Clearmind Medicine Inc. Common Shares (CMND)

US · Healthcare · Biotechnology

$1.71+4.91%

Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue

Net profit

$-2.0M

Profit YoY

-161.0%

EPS

$-6.78

Key statistics

Market cap

$2.5M

Forward P/E

0.0

P/B

0.22

Book value

$11.28

EPS (TTM)

$-175.92

52-week high

$524.00

52-week low

$1.43

50-day MA

$2.47

200-day MA

$52.85

Beta

-1.18

Shareholding

Insiders

0.09%

Institutions

128.64%

Largest institutional holders

Fund	Stake
XTX Topco Ltd	0.21%
HRT FINANCIAL LLC	0.16%
AdvisorShares Investments, LLC	0.07%
Royal Bank of Canada	0.00%
UBS Group AG	0.00%
JPMorgan Chase & Co	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Clearmind Medicine Inc. Common Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.